Larimar Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Larimar Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Larimar Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Larimar Therapeutics by Connor, Clark & Lunn Investment Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $154k | 24k | 6.55 |
2024-06-30 | $173k | 24k | 7.25 |
2024-03-31 | $441k | 58k | 7.59 |
2023-09-30 | $86k | 22k | 3.95 |
2023-06-30 | $151k | 48k | 3.13 |
2023-03-31 | $190k | 42k | 4.53 |
2022-12-31 | $155k | 38k | 4.13 |
2022-09-30 | $42k | 13k | 3.21 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management